AVITA Medical Statistics
Total Valuation
AVITA Medical has a market cap or net worth of $312.05 million. The enterprise value is $349.40 million.
| Market Cap | 312.05M |
| Enterprise Value | 349.40M |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVITA Medical has 30.93 million shares outstanding. The number of shares has increased by 14.29% in one year.
| Current Share Class | 30.93M |
| Shares Outstanding | 30.93M |
| Shares Change (YoY) | +14.29% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 1.47% |
| Owned by Institutions (%) | 16.18% |
| Float | 30.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.13 |
| Forward PS | 3.14 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.41
| Current Ratio | 0.41 |
| Quick Ratio | 0.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -41.56% |
| Return on Invested Capital (ROIC) | -84.11% |
| Return on Capital Employed (ROCE) | 168.20% |
| Weighted Average Cost of Capital (WACC) | 14.23% |
| Revenue Per Employee | $334,650 |
| Profits Per Employee | -$190,628 |
| Employee Count | 226 |
| Asset Turnover | 1.43 |
| Inventory Turnover | 2.18 |
Taxes
In the past 12 months, AVITA Medical has paid $21,000 in taxes.
| Income Tax | 21,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +107.19% in the last 52 weeks. The beta is 1.85, so AVITA Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.85 |
| 52-Week Price Change | +107.19% |
| 50-Day Moving Average | 5.26 |
| 200-Day Moving Average | 4.39 |
| Relative Strength Index (RSI) | 81.20 |
| Average Volume (20 Days) | 725,776 |
Short Selling Information
The latest short interest is 2.61 million, so 8.51% of the outstanding shares have been sold short.
| Short Interest | 2.61M |
| Short Previous Month | 2.62M |
| Short % of Shares Out | 8.51% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 9.39 |
Income Statement
In the last 12 months, AVITA Medical had revenue of $75.63 million and -$43.08 million in losses. Loss per share was -$1.44.
| Revenue | 75.63M |
| Gross Profit | 61.68M |
| Operating Income | -35.22M |
| Pretax Income | -43.06M |
| Net Income | -43.08M |
| EBITDA | -32.76M |
| EBIT | -35.22M |
| Loss Per Share | -$1.44 |
Balance Sheet
The company has $11.14 million in cash and $48.48 million in debt, with a net cash position of -$37.35 million or -$1.21 per share.
| Cash & Cash Equivalents | 11.14M |
| Total Debt | 48.48M |
| Net Cash | -37.35M |
| Net Cash Per Share | -$1.21 |
| Equity (Book Value) | -27.84M |
| Book Value Per Share | -0.90 |
| Working Capital | -40.32M |
Cash Flow
In the last 12 months, operating cash flow was -$24.23 million and capital expenditures -$387,000, giving a free cash flow of -$24.61 million.
| Operating Cash Flow | -24.23M |
| Capital Expenditures | -387,000 |
| Depreciation & Amortization | 2.45M |
| Net Borrowing | 6.10M |
| Free Cash Flow | -24.61M |
| FCF Per Share | -$0.80 |
Margins
Gross margin is 81.56%, with operating and profit margins of -46.56% and -56.96%.
| Gross Margin | 81.56% |
| Operating Margin | -46.56% |
| Pretax Margin | -56.94% |
| Profit Margin | -56.96% |
| EBITDA Margin | -43.32% |
| EBIT Margin | -46.56% |
| FCF Margin | n/a |
Dividends & Yields
AVITA Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.29% |
| Shareholder Yield | -14.29% |
| Earnings Yield | -13.81% |
| FCF Yield | -7.89% |
Analyst Forecast
The average price target for AVITA Medical is $11.06, which is 9.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.06 |
| Price Target Difference | 9.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 23.27% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 30, 2020. It was a reverse split with a ratio of 1:5.
| Last Split Date | Jun 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
AVITA Medical has an Altman Z-Score of -13.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.31 |
| Piotroski F-Score | 2 |